--- title: 6505--Imatinib Tablets | Due Oct 30, 2026 - MatchAwards description: 6505--Imatinib Tablets. United States Department of Veterans Affairs. Solicitation 36E79726R0036. NAICS 325412 - Pharmaceutical Preparation Manufacturing. Deadline 2026-10-30. PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79726R0036... canonical: https://matchawards.com/department_of_veterans_affairs/posts/117390511298818752 og:image: https://matchawards.com/home_logo.png og:image:width: 130 og:image:height: 130 twitter:card: MatchAwards.com twitter:image: https://matchawards.com/home_logo.png og:site_name: MatchAwards og:type: article og:title: 6505--Imatinib Tablets | Due Oct 30, 2026 og:url: https://matchawards.com/department_of_veterans_affairs/posts/117390511298818752 og:description: 6505--Imatinib Tablets. United States Department of Veterans Affairs. Solicitation 36E79726R0036. NAICS 325412 - Pharmaceutical Preparation Manufacturing. Deadline 2026-10-30. PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79726R0036... og:image: https://matchawards.com/system/accounts/avatars/000/000/015/original/f59915e906ee2b19.png?1638825904 og:image:width: 120 og:image:height: 120 twitter:card: summary --- # 6505--Imatinib Tablets Agency [United States Department of Veterans Affairs](/department%5Fof%5Fveterans%5Faffairs) Office HINES, USA Notice type Presolicitation Solicitation number 36E79726R0036 NAICS [325412 - Pharmaceutical Preparation Manufacturing](/groups/360) PSC 6505 - DRUGS AND BIOLOGICALS Category [Drugs and Pharmaceutical Products (10.1)](/categories/medical/drugs-and-pharmaceutical-products) Posted 2026-10-16 Deadline 2026-10-30 ## Description PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79726R0036 for an unrestricted procurement for Imatinib Mesylate Tablet, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 - 2, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0036 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 16, 2026, with a tentative closing date of October 30, 2026\. The NAICS code for this procurement is 325412\. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Andrew Cazares. Questions can be e-mailed to Andrew.Cazares@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 Imatinib Mesylate 100MG Tablet 90 6,397 2 Imatinib Mesylate 400MG Tablet 30 23,212 ## Attachments * [Attachment 1](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/7828dd0573ae4fe181e12567d62f1a10/download) * [Attachment 2](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/905e1bb736994210a97e8c88dbdd79f7/download) ## Contacts * Andrew Cazares, Contract Specialist Email and phone are in the source notice. [Source notice](https://sam.gov/workspace/contract/opp/045dd623c0954c82a0dbd8f76c430210/view) ```json {"@context":"https://schema.org","@type":"Demand","name":"6505--Imatinib Tablets","description":"PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79726R0036 for an unrestricted procurement for Imatinib Mesylate Tablet, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 - 2, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0036 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 16, 2026, with a tentative closing date of October 30, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Andrew Cazares. Questions can be e-mailed to Andrew.Cazares@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 Imatinib Mesylate 100MG Tablet 90 6,397 2 Imatinib Mesylate 400MG Tablet 30 23,212","url":"https://matchawards.com/department_of_veterans_affairs/posts/117390511298818752","identifier":"36E79726R0036","category":"325412 - Pharmaceutical Preparation Manufacturing","additionalProperty":[{"@type":"PropertyValue","propertyID":"PSC","name":"PSC","value":"6505 - DRUGS AND BIOLOGICALS"},{"@type":"PropertyValue","propertyID":"CM category","name":"Category Management category","value":"10.1 Drugs and Pharmaceutical Products","url":"https://matchawards.com/categories/medical/drugs-and-pharmaceutical-products"}],"availabilityStarts":"2026-10-16","availabilityEnds":"2026-10-30","sameAs":"https://sam.gov/workspace/contract/opp/045dd623c0954c82a0dbd8f76c430210/view"} ```